SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) have received a consensus rating of “Buy” from the thirteen ratings firms that are covering the firm, MarketBeat reports. One analyst ...
ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has received a consensus rating of “Moderate Buy” from the six research firms that are covering the company, Ratings reports. Three ...
The Andaman cobra is one of the rarest and least known of all cobra species. It is endemic to the Andaman and Little Andaman ...
17h
News Medical on MSNScottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancerRegeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results